News & Analysis as of

Research and Development › Contract Terms

Foley & Lardner LLP

How Should Businesses Implement Artificial Intelligence Tools, Legally

Foley & Lardner LLP on

Business leaders, from CEOs to CIOs to project managers, are rapidly adopting generative artificial intelligence tools to transform their organizations, harnessing technology to drive efficiency, streamline processes, and...more

Holland & Knight LLP

Negotiating Cost Share in Technology Investment Agreements

Holland & Knight LLP on

Note: This is the second article in our series on capturing industrial base funding from the U.S. Department of Defense In our last post, we discussed the Defense Production Act (DPA) and Technology Investment Agreement...more

Pillsbury Winthrop Shaw Pittman LLP

Department of Energy Proposes to Revise its Acquisition Regulation

Pillsbury Winthrop Shaw Pittman LLP on

The DOE proposes to update and streamline its policies, procedures, provisions and clauses applicable to its contracts. The changes include revisions related to facility clearances, Agreements for Commercializing...more

Barnea Jaffa Lande & Co.

Material Transfer Agreements: Why They Matter

Barnea Jaffa Lande & Co. on

In the world of scientific research and development, sharing materials between organizations is a common practice. However, when such sharing involves proprietary materials or intellectual property, it becomes important to...more

TransPerfect Legal

What’s Trending: Milestone Disputes in Life Sciences Litigation

TransPerfect Legal on

Earlier this month, the ACC hosted an illuminating panel presentation on Life Sciences Litigation: A Look at Milestone Disputes & Recent Trends. Panelists included Lauri Mims and Jennifer Huber, both Partners at Keker Van...more

Goodwin

Survival Guide to Structuring Life Sciences Partnering and M+A Agreements

Goodwin on

The life sciences space is ever-growing and dynamic as the industry witnesses more companies and, therefore, more collaboration, licensing and M&A agreements, come into the spotlight. While these deals are exciting...more

Proskauer - Life Sciences

"Commercially Reasonable Efforts” Clauses in Drug Development Deals: What Level of Protection Do They Really Provide?

Proskauer - Life Sciences on

Pharmaceutical drug development is expensive. One recent study estimates that the median cost to develop a new drug is $985 million, while the average is $1.3 billion. And those figures appear to be on the low end of a broad...more

Goodwin

Leasing Models in Life Sciences and How They Correspond to the Life Cycle of a Company

Goodwin on

The real estate needs of life sciences companies can be fluid and complex, with early stage companies typically needing smaller flexible space and later stage companies typically requiring larger build-to-suit space. With an...more

Dechert LLP

Dispute Boards: A Novel Dispute-Resolution Technique for Life Sciences Companies Fighting COVID-19

Dechert LLP on

In these unprecedented times, life sciences companies are partnering up — sometimes in a matter of days — to find potential vaccines or treatments to the COVID-19 virus. In an effort to help the world beat the pandemic that...more

Orrick - Trade Secrets Group

Does California’s Ban on Non-Competes Apply to Business Agreements? The California Supreme Court May Weigh In Shortly.

Orrick - Trade Secrets Group on

The Ninth Circuit recently certified a question to the California Supreme Court regarding the scope of California Business & Professions Code Section 16600. As TSW readers are likely aware, Section 16600 states that “[e]very...more

10 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide